{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:45:11Z","timestamp":1786113911800,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","award":["IG2019 \\u201322805"],"award-info":[{"award-number":["IG2019 \\u201322805"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218704","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:19:20Z","timestamp":1783009160000},"page":"218704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Talazoparib engages innate immune activation via PARP trapping\u2013dependent cGAS\/STING activation in Ewing Sarcoma"],"prefix":"10.1016","volume":"657","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-1935","authenticated-orcid":false,"given":"Marianna","family":"Carrabotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-8118","authenticated-orcid":false,"given":"Lorena","family":"Landuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3242-2000","authenticated-orcid":false,"given":"Elisa","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Avnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-3166","authenticated-orcid":false,"given":"Francesca","family":"Ruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Salamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8080-4484","authenticated-orcid":false,"given":"Marco","family":"Gambarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier-Luigi","family":"Lollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Scotlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218704_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Grunewald","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218704_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","article-title":"EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma","volume":"26","author":"Riggi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218704_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature25748","article-title":"EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma","volume":"555","author":"Gorthi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218704_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jamaoncol.2015.5699","article-title":"Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors","volume":"2","author":"Parsons","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218704_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/gim.2016.206","article-title":"Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma","volume":"19","author":"Brohl","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.canlet.2026.218704_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216507","article-title":"Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma","volume":"582","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218704_bib8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1158\/0008-5472.CAN-11-3648","article-title":"PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma","volume":"72","author":"Brenner","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1078-0432.CCR-14-2572","article-title":"Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program","volume":"21","author":"Smith","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28073","article-title":"Phase 1\/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory\/recurrent solid tumors including ewing sarcoma: a Children's Oncology Group phase 1 consortium study (ADVL1411)","volume":"67","author":"Schafer","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.33349","article-title":"SARC025 arms 1 and 2: a phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma","volume":"127","author":"Chugh","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae096","article-title":"Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial","volume":"29","author":"Glade Bender","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218704_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/1471-2407-14-813","article-title":"Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy","volume":"14","author":"Choy","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.CCR-25-3767","article-title":"Phase I\/II study of the PARP inhibitor olaparib and Irinotecan in children and young adults with recurrent\/refractory malignancies: arm D of the AcSe-ESMART trial","volume":"32","author":"Gatz","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly(ADP-ribose) polymerase inhibition: past, present and future","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.seminoncol.2023.08.001","article-title":"PARP1 roles in DNA repair and DNA replication: the basi(c)s of PARP inhibitor efficacy and resistance","volume":"51","author":"Kanev","year":"2024","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2026.218704_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218704_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218704_bib19","article-title":"A non-canonical cGAS-STING pathway drives cellular and organismal aging","author":"Cancado de Faria","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218704_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1158\/2326-6066.CIR-19-0229","article-title":"STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity","volume":"7","author":"Falahat","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218704_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00262-017-1975-1","article-title":"Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site","volume":"66","author":"Ohkuri","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2026.218704_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218704_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110047","article-title":"Immuno-transcriptomic profiling of extracranial pediatric solid malignancies","volume":"37","author":"Brohl","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218704_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","article-title":"The genomic landscape of pediatric Ewing sarcoma","volume":"4","author":"Crompton","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1674113","article-title":"Prognostic profiling of the immune cell microenvironment in Ewing s sarcoma family of tumors","volume":"8","author":"Stahl","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2026.218704_bib27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/cas.15688","article-title":"Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma","volume":"114","author":"Zhang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218704_bib28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajpath.2011.05.034","article-title":"Macrophage infiltration predicts a poor prognosis for human ewing sarcoma","volume":"179","author":"Fujiwara","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218704_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.2819","article-title":"Pro-inflammatory chemokine-chemokine receptor interactions within the ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression","volume":"223","author":"Berghuis","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218704_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ejca.2009.11.018","article-title":"High metastatic efficiency of human sarcoma cells in Rag2\/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy","volume":"46","author":"Nanni","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48634-y","article-title":"Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations","volume":"9","author":"Nanni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218704_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/0008-5472.CAN-21-1222","article-title":"Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma","volume":"82","author":"Carrabotta","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-06-1762","article-title":"Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth","volume":"13","author":"Carrillo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib34","article-title":"Optimization of differentiation and transcriptomic profile of THP-1 cells into macrophage by PMA","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218704_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.canlet.2026.218704_bib36","first-page":"1","article-title":"Basic concept of development and practical application of animal models for human diseases","volume":"324","author":"Nomura","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.canlet.2026.218704_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122961","article-title":"Age-related tumor growth in mice is related to integrin alpha 4 in CD8+ T cells","volume":"3","author":"Oh","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218704_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117242","article-title":"Correlation between mouse age and human age in anti-tumor research: significance and method establishment","volume":"242","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2026.218704_bib39","doi-asserted-by":"crossref","first-page":"21172","DOI":"10.1021\/acs.jmedchem.5c01111","article-title":"Discovery of dCDK9-202 as a highly potent and selective PROTAC CDK9 degrader with strong in vivo antitumor activity","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218704_bib40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/2767-9764.CRC-24-0346","article-title":"TGFbeta inhibition during radiotherapy enhances immune cell infiltration and decreases metastases in ewing sarcoma","volume":"5","author":"Daley","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2026.218704_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218704_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2020.01.006","article-title":"Automated quantification of immunohistochemical staining of large animal brain tissue using QuPath software","volume":"429","author":"Morriss","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.canlet.2026.218704_bib43","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2026.218704_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","article-title":"Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib","volume":"13","author":"Murai","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218704_bib45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218704_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121979119","article-title":"Inhibitors of PARP: number crunching and structure gazing","volume":"119","author":"Rudolph","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218704_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218704_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218704_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib50","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218704_bib51","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-dependent antitumor immunity in Brca1-Deficient ovarian cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218704_bib52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218704_bib53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s43018-020-00148-7","article-title":"Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer","volume":"2","author":"Mehta","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib54","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218704_bib55","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","article-title":"Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production","volume":"37","author":"Konno","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218704_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013598118","article-title":"Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma","volume":"118","author":"Falahat","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218704_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2022.04.009","article-title":"Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition","volume":"40","author":"Low","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218704_bib58","article-title":"STING activation reshapes the tumor microenvironment leading to tumor regression in osteosarcoma","author":"Young","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218704_bib59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/1078-0432.CCR-23-2187","article-title":"Surface and global proteome analyses identify ENPP1 and other surface proteins as actionable immunotherapeutic targets in ewing sarcoma","volume":"30","author":"Mooney","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313693120","article-title":"ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218704_bib61","article-title":"Tumor exosomal ENPP1 hydrolyzes cGAMP to inhibit cGAS-STING signaling","volume":"11","author":"An","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218704_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s43018-025-01100-3","article-title":"CDK10 suppresses nucleic acid sensors-mediated antitumor immunity","volume":"7","author":"Xu","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020392","article-title":"Immunomodulatory roles of PARP-1 and PARP-2: impact on PARP-centered cancer therapies","volume":"12","author":"Yelamos","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218704_bib64","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1158\/1078-0432.CCR-21-1278","article-title":"Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a hereditary BRCA mutation","volume":"28","author":"Kumar","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218704_bib65","doi-asserted-by":"crossref","first-page":"34141","DOI":"10.18632\/oncotarget.9388","article-title":"Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model","volume":"8","author":"Minas","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218704_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2022.1062705","article-title":"Benefits and limitations of humanized mouse models for human red blood cell-related disease research","volume":"1","author":"Chen","year":"2023","journal-title":"Front. Hematol."},{"key":"10.1016\/j.canlet.2026.218704_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejca.2020.06.014","article-title":"A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies","volume":"137","author":"Federico","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218704_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162687","article-title":"Targeting macrophages in glioblastoma: current therapies and future directions","volume":"17","author":"Pennisi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218704_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:05:33Z","timestamp":1785960333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"alternative-id":["S0304383526004684"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218704","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Talazoparib engages innate immune activation via PARP trapping\u2013dependent cGAS\/STING activation in Ewing Sarcoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218704"}}